Nanocyl Exhibits Carbon Nanotube Technologies at Chinaplas 2011

Nanocyl has exhibited its carbon nanotube technologies for use in composite sporting goods and automotive electronics at Chinaplas 2011. The company showcased the NC 7000 and the EPOCYL CNTs.

Electrically conductive carbon nanotubes (CNTs) called the NC 7000 thin multiwall were displayed at the event. These materials are of small size and have nearly perfect chemical surface. The NC 7000 CNTs have high aspect ratio, which provides higher conductive performance at lower concentration.

The other product line that was exhibited was the EPOCYL specially-formulated CNTs. These epoxy resins provide the necessary benefits for application in sports, marine, automotive and aerospace. Benefits include weight reduction, durability, structural strength and conductivity. The EPOCYL is used in fiber-reinforced composite products.

Nanocyl’s new 400 mt reactor delivers high conductive and the cleanest carbon nanotube technologies to the market. The CNTs that are used in the automotive industry provide excellent resistance to fuel and also offer more cleanliness and electrostatic discharge (ESD) properties for electronics applications. The CNTs are used in the sporting goods sector, which needs durability and strength for higher performance.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nanocyl, S.A.. (2019, February 09). Nanocyl Exhibits Carbon Nanotube Technologies at Chinaplas 2011. AZoM. Retrieved on July 18, 2024 from https://www.azom.com/news.aspx?newsID=29257.

  • MLA

    Nanocyl, S.A.. "Nanocyl Exhibits Carbon Nanotube Technologies at Chinaplas 2011". AZoM. 18 July 2024. <https://www.azom.com/news.aspx?newsID=29257>.

  • Chicago

    Nanocyl, S.A.. "Nanocyl Exhibits Carbon Nanotube Technologies at Chinaplas 2011". AZoM. https://www.azom.com/news.aspx?newsID=29257. (accessed July 18, 2024).

  • Harvard

    Nanocyl, S.A.. 2019. Nanocyl Exhibits Carbon Nanotube Technologies at Chinaplas 2011. AZoM, viewed 18 July 2024, https://www.azom.com/news.aspx?newsID=29257.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.